Key Takeaways Elevance will exit standalone Part D and scale back underperforming Medicare Advantage markets.The insurer will focus on HMO and D-SNP plans, which offer stronger margins.ELV cut its 2025 EPS outlook to $30, down from the prior$34.15-$34.85, amid rising medical costs.Elevance Health, Inc. (ELV) is reshaping its Medicare strategy by stepping away from certain underperforming Medicare Advantage markets and fully exiting the standalone Part D segment. The move comes as health insurers brace for ...